High yielding adenovirus (Ad)-hepatitis B recombinant (Ad-Hep B) viruses were prepared by insertion of the hepatitis B surface antigen (HBsAg) gene into the early region 3 (E3 region) of Ad4 or Ad7 vectors containing intact or largely deleted E3 regions. Both E3-deleted and non-deleted recombinants produced about six-to eightfold higher amounts of HBsAg than previously reported recombinants. These recombinant viruses were evaluated for immunogenicity in dogs which sustain abortive lung infections by Ad4 and Ad7. Recombinants containing E3 deletions elicited 10-to 12-fold stronger antiHBs primary responses than previously evaluated low yield recombinants. 
Introduction
The idea of using adenovirus (Ad) vectors as vehicles for delivery of heterologous genes has received considerable attention in recent years due to the inherent potential advantages associated with such a live vector approach. The deletion of the non-essential E3 region of Ad has facilitated construction of viable and helper-independent viruses containing insertions of large foreign genes under control of either early or late promoters (Haz-Ahmed & Graham, 1986; Tikchonenko, 1989; Morin et al., 1990 ; Mason et al., 1990; Chengalvala et al., 1991a) . During infection of susceptible cell lines, such recombinant viruses produce large amounts of foreign proteins which have been shown to undergo proper post-translational modifications including glycosylation and phosphorylation Molnar-Kimber et al., 1988) . Live oral vaccines against Ad4 and Ad7 have been shown to be safe and efficacious by oral immunization (Top et al., 1971) , making these Ad strains particularly attractive as vectors (Berkner, 1988; Johnson, 1991) .
The E3 region of Ad is thought to play an important role in viral pathogenesis by protecting virus-infected cells from early eradication by the host immune system (Wold & Gooding, 1991) . E3-encoded gp19K glycoprotein (Wold et al., 1985) reduces the expression of class 1 major histocompatibility complex antigens on the surface of infected cells thereby inhibiting cytotoxic T cells from attacking them (Ginsberg et al., 1989; Burgert et al., 1987; Wold & Gooding, 1991) . Other E3 proteins, particularly the 14.7K protein, have been implicated in protecting Ad-infected ceils from lysis by tumour necrosis factor (Ginsberg et al., 1989) and downregulating the EGF receptor in concert with another E3 protein, 10.4K (Carlin et al., 1989; Tollefson et al., 1991) . These findings suggest that, although the E3 region of the Ad genome is non-essential for replication of the virus, it contains genes necessary for evading host immune responses, thereby promoting establishment of long term infection in vivo. Thus, although E3 deleted mutants have the advantage of allowing larger foreign genes to be inserted in the Ad genome, it has been suggested that their inability to counter host immune responses in their natural host may result in a shorter duration of infection and, hence, relatively poor antibody responses against the foreign gene product.
Since the discovery of adenoviruses 4 decades ago, only cotton rats (Pacini et al., 1984) and hamsters 0001-1853 © 1994 SGM (Hjorth et al., 1988; Morin et al., 1987) have been identified as small animal models for permissive Ad infection. However, these rodent models are permissive only for certain human Ad serotypes and do not support replication of Ad4 or Ad7. Recently we have described two animal models for these serotypes, the dog (Chengalvala et al., 1991b) and the chimpanzee (Lubeck et al., 1989) . In the dog model, immunogenicity studies involving Ad4-and Ad7-vectored vaccines require direct virus inoculation into the lungs where abortive infection occurs, whereas the chimpanzee represents the sole permissive model for enteric replication of these Ads. The limited availability and cost associated with chimpanzees preclude their routine use for screening potential recombinant vaccines, thereby resulting in the use of the dog model for screening Ad4 and Ad7 vaccine candidates.
In the present study, we have evaluated the immunogenicity of two types of Ad-hepatitis (Hep B) B virus recombinants, one containing a large E3 deletion with the hepatitis B surface antigen (HBsAg) gene substituted in the E3 region, and a second, which contains an E3 insertion of the HBsAg gene without a concomitant deletion in the E3 region. The former viruses induced strong anti-HBs responses in dogs whereas the latter failed to do so, even though both types of virus elicit comparable anti-Ad neutralizing responses and produce high amounts of HBsAg in A549 cells.
Methods
Recombinant viruses. The Wyeth-Ayerst vaccine strains of Ad4 (CL 68578) and Ad7 (55142) were used for the construction of recombinant viruses. These viruses were grown and titrated on the A549 human lung carcinoma cell line. Whenever necessary, viruses were purified by (a) so AE3 88 oD E3 ~--~E3BpAlOO~ 5.31 (Morin et al., 19901) . The basic genetic structure of the AE3H and E3+H recombinants is represented schematically in Fig. 1 .
Kinetics of HBsAg production. The kinetics of HBsAg expression by Ad recombinants was determined in two cell types, the first, the A549 cell line originating from a human tung carcinoma and the second, the MDCK cell line, of canine kidney origin. In A549 cells, both Ad4 and Ad7 viruses complete their infectious life cycles and lead to virus production, whereas in the MDCK cell line these viruses cause abortive or non-productive infections. The cell monolayers were incubated at 37 °C with the viruses in a multiwell plate at an m.o.i, of 10 and the cells were harvested at different time points. The cell lysates were assayed for HBsAg using the AUSRIA test kit (Abbott Laboratories). The results are expressed as the ratio of HBsAg accumulated in E3 + compared to AE3 recombinant Ad-infected cell cultures.
Inoculation of dogs.
Approx. 6-to 12-month-old beagles (Marshall Farms) were screened for pre-existing serum antibodies to Ad4 and Ad7 by microneutralization analysis (Chengalvala eta[., 1991b) and for anti-HBs titres by the AUSAB kit (Abbott Laboratories). Briefly, in this radioimmunoassay (RIA), samples are incubated for 18 h with polystyrene beads coated with HBsAg after which the beads are washed and incubated for 4 h with ~Si-labelled HBsAg. After removal of the unbound radioactivity, the samples were counted in a gamma counter. Only those animals having Ad neutralization titres of < 4 and antiHBs titres of < 4 x 10 ~ International Units (mIU) were selected. Infectious virus or u.v.-inactivated virus was inoculated directly into dog lungs by the trans-tracheal route. Booster immunizations with heterotypic viruses were given at 12 weeks after primary inoculations.
Serology. Serum samples were incubated at 56 °C for 30 min for complement inactivation and serial twofold serum dilutions, beginning with 1:4, were used in a microneutralization method to measure antiAd antibodies as described earlier (Chengalvala et al., 1991 b) . Briefly, diluted samples were incubated with 30 to 100 TC1Ds0 virus on A549 cell monolayers for 8 to 10 days at 37 °C in 5% CO 2. Cells were examined for cytopathic effect (c.p.e.) and titres were expressed as the reciprocal of the lowest serum dilution at which 25 % c.p.e, was observed. Antibody responses against HBsAg were detected using the AUSAB test kit and expressed in mIU based on a conversion factor of 4 RIA units per 1 mIU.
Detection of anti -~ a' antibodies.
The presence of anti-' a' antibodies in dog sera was detected by a competition RIA that was described in detail elsewhere (Chengalvala et al., 1991b) . Briefly, monoclonal antibody reactive with the 'a" antigenic determinant of HBsAg was labelled with ~Sl and incubated with HBsAg in the presence or absence of dog sera. The degree of inhibition of the binding of labelled antibody to HBsAg by the serum sample was calculated in comparison with the binding obtained using pre-immune serum.
Results

Comparative analysis of HBsAg expression by AE3H and E3+H recombinants
The amount of HBsAg produced by E3+H and AE3H recombinants was compared at different time points in two cell lines (Table 1) . In A549 cells, which support productive infection, both early and late genes are efficiently expressed leading to the production of infectious virus particles. As shown in Table 1 , the ratio of HBsAg accumulated in E3+H and AE3H recombinantinfected A549 cells gradually increased from 0-14 to 2-13 over a 72 h time period. Most of the HBsAg expression by AE3H viruses took place at early time points, that is before 24 to 36 h, whereas with E3+H viruses the HBsAg accumulation took place at or after 36 h. In contrast, in a canine cell line, MDCK, wherein only abortive or semipermissive infection of human adenoviruses take place, the ratio of HBsAg accumulation is only 0.14 to 0-18 even after 144 h post-infection, indicating that there is apparently no late expression of the HBsAg gene in this cell line. It should be noted that in AE3H viruses, HBsAg is the major protein expressed using the E3 promoter and, even in permissive A549 cells, it is only about 24 h post-infection when the secreted and accumulated form of HBsAg can be detected by the AUSRIA test. Hence, the first measurable HBsAg production from the E3 promoter during early times is around 24 h post-infection in A549 cells for these recombinants.
Virus replication hi dog lungs
Ad4AE3H, Ad4H, Ad7AE3H and Ad7H were evaluated for their ability to replicate in the lungs of dogs and induce lung histopathology following trans-tracheal inoculations (10 s p.f.u.). Neither Ad4AE3H nor Ad4H persisted in lungs for more than 1 day following lung inoculations. In contrast, a low level of Ad7AE3H (1 to 10 p.f.u./g tissue) was recovered from lungs up to 8 days and Ad7H was found in lungs for 3 days post-inoculation (data not shown). Lung sections from dogs inoculated with Ad4-or Ad7-Hep B viruses did not exhibit even minimal histological changes characteristic of Ad infections (data not shown).
ImmunogeniciO, of Ad-Hep B recombinants
Dogs received a single inoculation of purified virus (either Ad4AE3H, Ad4H, Ad7AE3H or Ad7H) over a dose range of 10 v to 109 p.f.u. Control animals received high-dose inocula (10 ~ p.f.u.) that had been inactivated with u.v. irradiation. All animals receiving live virus showed significantly elevated anti-Ad neutralizing antibody responses by 2 weeks post-inoculation (Table 2) . Elevated levels were maintained for several weeks with responses peaking at around 4 weeks. The results were essentially the same for both the AE3 and E3 + sets of viruses. Control animals did not show detectable increases in anti-Ad antibody titres indicating that virus expression was necessary for induction of the responses. As shown in Table 3 , Ad4AE3H and Ad7AE3H elicited high anti-HBs titres as early as 2 weeks following inoculation and the responses appeared to be dosedependent. The titres, which were greatest at around 4 weeks, remained elevated for several weeks, though a declining trend was noticed in some animals after 12 weeks post-inoculation. 
Fine specific±O, analysis of anti-HBs response
The quality of anti-HBs responses in dogs immunized with Ad4AE3H amd Ad7AE3H was evaluated by competitive binding analysis. Inhibition of l~SI-labelled anti-'a' monoclonal antibody binding to HBsAg was used to probe for induced anti-'a' antibodies. The percentage inhibition of labelled antibody binding was calculated using pre-immune serum sample as a negative control (100 % binding). As shown in Table 5 , sera from dogs immunized with Ad4AE3H or Ad7AE3H significantly inhibited the binding of labelled antibody. The magnitude of binding inhibition is comparable to that obtained using sera from dogs immunized with a hepatitis B virus subunit vaccine (Table 5) . Sera from control animals (no. 575 and 699) did not inhibit the binding of anti-' a' monoclonal antibody to HBsAg.
Effect of booster immunizations with heterot)Tic viruses
In this experiment, dogs received Ad4AE3H or Ad7AE3H as the primary immunogen and 12 weeks later were boosted with heterotypic virus (either Ad7AE3H or Ad4AE3H). Following primary immunizations, animals developed strong anti-Ad (data not shown) and antiHBs responses (Tables 6). Control animals (262 and 257) did not show significant seroconversion to either Ad or HBsAg. Following booster immunizations, animals that showed significant primary anti-HBs responses developed elevated anti-HBs titres, with peak titres, in the range of 4275 to 220000 mIU, by 2 weeks. These high titres persisted for an extended period of time. In animals 262 and 257, which received u.v.-irradiated virus as an initial inoculum, the heterotypic second inoculation elicited strong primary responses. 
Discussion
The present study was carried out to evaluate the immunogenicity of two sets of high expression Ad--Hep B recombinants. The first set of recombinants was engineered by deleting a large portion of the E3 region (about 3 kb or 8 m.u.) and inserting, in that locus, the HBsAg gene. HBsAg expression, by such recombinants, takes place primarily during the early phases of the Ad replication cycle as described earlier (Morin et al., 1987) . However, the overall accumulation of HBsAg, during the productive infection of the A549 cell line by these recombinants, was about four-to sixfold greater than observed for the previous AE3 constructs, WyAd7HZ6-1 and WyAd4HHxs, which do not contain the TPL sequences (Chengalvala et al., 1991b) . Although these new Ad7AE3H and Ad4AE3H viruses express HBsAg mainly during early times, due to the presence of the TPL, late mRNAs from the E3 region may also be translated. The presence of late stage major late promoter-driven mRNAs passing through the E3 region of adenovirus has been reported earlier Bhat et al., 1986) . The TPL-mediated enhanced expression of a given foreign gene during late stages of Ad infection has also been documented (Logan & Shenk, 1984; Berkner, 1988) . Several other investigators have reported the generation of non-defective recombinants using an Ad5 vector in which part of the E3 region was replaced with foreign genes such as herpes simplex virus (HSV) thymidine kinase (Haj-Ahmed & Graham, 1986) , vesicular stomatitis virus glycoprotein , human immunodeficiency virus (Dewar et al., 1989), human cytomegalovirus major envelope glycoproteins (Marshall et at., 1990) , and HSV glycoprotein (Johnson, 1991) . All of these recombinants express good amounts of foreign protein h~ vitro (quantitative aspects of expression are not reported) and have been shown to induce seroconversion successfully in small animals. However, it is difficult to compare them meaningfully with our Ad4-and Ad7-HepB viruses because the level of expression of the inserted gene depends upon the foreign sequences as well as on the serotype used. In addition, the/eve! of expression of the foreign gene can be modulated by including or deleting several cis-acting elements .
The second set of viruses contains the entire E3 region with the insertion of the HBsAg gene as the last open reading frame (ORF) in the E3 region. As shown in Table 1 , the E3-containing recombinants produced only 14 % of the amount of HBsAg when compared with the AE3 recombinant at 24 h post-infection. In contrast, during later times (36 to 72h), the ratio changed dramatically to yield 129 to 213 % of the AE3 recombinant. This indicated that during a productive infection ofA549 cells by E3 + recombinants, the HBsAg gene, even though located in the E3 region, is translated vers/poorly during early stages of infection. This could be because it is present as the last ORF. As in the conventional ribosome scanning model (Kozak, 1978) for translation, the second or the last ATG is not efficiently used, and it has been reported that the presence of TPL just upstream has a significant effect on translation only during late stages of infection (Logan & Shenk, 1984) , as we observed in these E3 + recombinants. This type of difference in the temporal expression between these two recombinants has been further supported when they were tested in a semi-permissive canine MDCK cell line. As shown in Table 1 , the ratio of E3 + to AE3 recombinant was only 0.15 to 0"18 in the canine cells, even after 144 h post-infection. It was reported earlier that another serotype of human Ad (Ad5) shows only abortive infection in this cell line .
The anti-HBs responses induced by the E3-deleted Ad4 and Ad7 viruses are approximately 10-to 15-fold higher than those elicited by previously studied E3-deleted recombinants (Chengalvala et aL, 1991b) . This enhanced immunogenicity is likely due to the ability of these new recombinant viruses to produce four-to sixfold more HBsAg than their previous counterparts. In addition, anti-'a' epitope antibodies were induced in animals showing high anti-HBsAg responses. Since the 'a' epitope is considered to be highly dominant and antibodies reactive with it have been shown to neutralize viral infectivity (Iwarson et al., 1985; Bhatnagar et al., 1982) , it would be predicted that the Ad-Hep B recombinants are able to induce protective immunity.
The present study has further strengthened our earlier report that sequential immunization with heterotypic Ad-Hep B viruses amplifies anti-HBs responses (Chengalvala et al., 1991b) . Both Ad4AE3H and Ad7AE3H viruses elicited strong booster responses in previously immunized dogs, far greater than the 10 mIU threshold considered to be protective in humans. These data confirm that antigenically distinct Ad serotypes can be exploited as vectors for sequential immunization purposes.
Recombinants possessing intact or deleted E3 regions failed to induce Ad-related histopathology in dog lungs. This observation is in contrast to the cotton rat model, in which Ginsberg et al. (1989) reported that E3-deleted Ad induces enhanced pneumonia and alterations in the inflammatory response to viral infection. This discrepancy in the lack of E3 effect may be attributed to differences in the interaction of Ad proteins with the immune systems of the two species used as animal models. Alternatively, the observed differences in pathology may be due to either differences in the Ad serotypes used in the two studies or the permissiveness of the two models (cotton rat lungs are permissive to Ad5 infection whereas dog lungs sustain abortive or semipermissive infections by Ad4 and Ad7).
The E3-deleted and E3-intact recombinant viruses used in this study both produce high quantities of HBsAg during infection of a permissive cell line (A549 cells). In addition, their replication kinetics in several different human cell lines showed only minor differences as compared to the striking differences in anti-HBsAg immune responses observed in dogs. When administered via the trans-tracheal route, both types of viruses induced strong anti-Ad neutralizing antibodies, even though the extent of Ad replication in dog lungs is minimal. Nevertheless, only recombinant viruses possessing large E3 deletions generated long lasting and high titred antiHBs antibody responses, whereas Ad4H and Ad7H viruses failed to elicit consistent anti-HBs responses. The reason for this difference is poorly understood at present. However, it may be related to the observation that the two sets of viruses differ in temporal expression of the HBsAg gene insert as indicated earlier in this section. E3-deleted viruses synthesize HBsAg protein mainly early and also late during the virus replication cycle, whereas the Ad4H and Ad7H viruses produce HBsAg mostly during late times of infection after the viral DNA replication ( Table 1 ). The late stage major late promoter-driven transcription of the recombinant Ad4H and Ad7H genomes may not proceed to the end of the E3 region during abortive infection of dog cells, thus blocking full expression of the HBsAg gene which would otherwise take place in a fully permissive system . Furthermore, early E3 transcripts containing the HBsAg gene, if made, would probably not allow the efficient translation of the HBsAg part of the message owing to placement of the gene as the last ORF. The lack of high expression of HBsAg in canine cells (Table 1 ) also substantiates the above interpretation in vivo, wherein the Ads undergo abortive infection. Under these circumstances in AE3 recombinants the HBsAg gene, being the first ORF, would be translated efficiently at early times even without a productive infection. Hence, the dog immunogenicity model may have a strong bias against heterologous proteins expressed late in the Ad replication cycle. Nonetheless, the dog has been proven to be a useful model for the evaluation of recombinant viruses that express heterologous proteins as early gene products and that do not require efficient viral DNA replication. Direct comparative evaluation of the immunogenicity of these two types of high-yield Ad-Hep B vaccines will require the use of the chimpanzee, which appears to be fully permissive for the enteric replication of Ad4 and Ad7 vectors (Lubeck et al., 1989) . The present study indicates that the E3-deleted high yield recombinants represent potential hepatitis B vaccine candidates which could be further evaluated.
